Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-09

Clinical Trial Update: Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the efficacy of the combination of Oncoxin and Viusid for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ONCOXIN
  • Viusid

Snippet

Sponsor: Catalysis SL | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED